Protein biomarkers (proteomics) in relation to risk of cardiometabolic diseases.
Dnr:
simp2020014
Type:
SNIC SENS
Principal Investigator:
Olga Titova
Affiliation:
Uppsala universitet
Start Date:
2020-10-19
End Date:
2024-11-01
Primary Classification:
30302: Public Health, Global Health, Social Medicine and Epidemiology
Webpage:
Allocation
- Castor /proj at UPPMAX: 300 GiB
- Cygnus /proj at UPPMAX: 300 GiB
- Castor /proj/nobackup at UPPMAX: 128 GiB
- Cygnus /proj/nobackup at UPPMAX: 128 GiB
- Bianca at UPPMAX: 1 x 1000 core-h/month
Abstract
The associations of different protein biomarkers with risk of cardiometabolic disease have not been fully established. The aim of this project is to assess the role of protein biomarkers (proteomics) for risk of various cardiometabolic diseases, with focus on ischemic heart disease (myocardial infarction), ischemic stroke, hemorrhagic stroke, heart failure, atrial fibrillation, abdominal aortic aneurysm, aortic valve stenosis, venous thromboembolism, and type 2 diabetes mellitus.